Srinivas Raghavan Viswanathan

Dana-Farber Cancer Inst

$4,974,293

Attributed

$6,552,737

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3M · FY2021–25

$5M$3.8M$2.5M$1.3M$0

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$6,552,737 · 6

By mechanism

R01$5,297,667 · 3

R21$718,909 · 2

U01$536,161 · 1

Top collaborators

Cheng-Zhong Zhang3 shared
Kent W Mouw2 shared

Most similar at Dana-Farber Cancer Inst

Same institution · by research overlap

Timothy R Rebbeck$50,819,475
Steven P. Balk$19,509,335
Kornelia Polyak$28,582,691
Rameen Beroukhim$9,639,646
Geoffrey I Shapiro$18,639,470

Others in their field

Other Emerging Leaders on “Genomics”

Leonard Freedman · Leidos Biomedical Research, Inc.$405,398,682
Scott Topper · Broad Institute, Inc.$153,234,573
Lynn Briscoe · Leidos Biomedical Research, Inc.$137,892,657
Leonard Freedmand · Leidos Biomedical Research, Inc.$96,686,407
Dwayne Forquer · Leidos Biomedical Research, Inc.$50,844,487
Scott Andrew Sutherland · Vignet, Inc.$37,105,117

Research focus

GenomicsCause Of DeathGenetic TranscriptionUnited StatesCellsMalignant NeoplasmsGenomic DataIn VivoMolecularCohortGenesDependenceIn Vivo ModelPathway InteractionsComplexNovel Therapeutic InterventionAutomobile DrivingIn VitroRegulationGenome-WideOncogenicPatient-Focused OutcomesGeneticInsight